Navigation Links
Breast Cancer Patients Experience a Faster Return to Normal Life
Date:10/8/2008

Radiation Therapy Treatment Takes Only Five Days

ARLINGTON, Va., Oct. 8 /PRNewswire-USNewswire/ -- A typical course of radiation therapy following breast cancer surgery involves 30 sessions over six weeks. But for certain women undergoing lumpectomy, Accelerated Partial Breast Irradiation (APBI), a newer radiation technology now available at Virginia Hospital Center, is allowing a faster return to normal life, with fewer side effects.

APBI, also known as "high dose rate breast brachytherapy", is a shortened course of high dose radiation therapy that targets the area of the breast where the cancer is most likely to recur. Unlike external beam radiation, which irradiates an entire region of breast tissue, APBI concentrates the radiation dose inside the cavity of the original tumor.

In APBI, a balloon filled with saline is temporarily embedded in the lumpectomy site following excision of the tumor. A radiation "seed" inserted into the balloon is then used to deliver radiation in a 360-degree motion inside the surgical cavity twice a day for five days. Each treatment session takes about seven minutes, and the entire course of therapy can be completed in just ten sessions.

"Concentrating the radiation precisely where the tumor used to be is strategic," explains Timothy M. Jamieson, MD, PhD, Medical Director of Radiation Oncology at Virginia Hospital Center. "Statistically, 95 percent of recurrence happens in the same quadrant of the original tumor, most often within one or two centimeters of the first malignancy."

The targeted nature of APBI also means less damage to healthy tissue, and therefore fewer side effects such as fatigue and skin burns. "The idea is that we can reduce the total volume of radiation by concentrating on the area of greatest risk (the tumor bed) without radiating healthy tissue," explains radiation oncologist Robert L. Hong, MD.

With the acquisition of MammoSite(R), a leading brand of APBI technology
'/>"/>

SOURCE Virginia Hospital Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Fans get a bigger thrill when on an emotional rol...v. 26 (HealthDay News) -- Call it the fear factor ...ggests that spectators -- especially those who roo...faction if it,s a closely contested match and vict...even despair. , Chew on that this Thanksgiving ...
(Date:11/26/2009)..., Research Triangle Denta...entral North Carolina, today announced the expansi...fied LUMINEER Dentist, Dr. Doug Macmillan. , ...rch Triangle Dental is pleased to announce that Dr...st, recently completed an additional advanced trai...
(Date:11/25/2009)...,, EDINA,Minn.,Nov.25/PRNewswire-USNewswire/...dentist.Butachiropractorcanalsogivepatientsthehelp...hichiswhereyourjaw(mandible)contacts/connectswithy...sassociatedwithTMJdysfunctionarepainwithchewing,cl...ausedfromTMJdysfunctionincluding:headaches,fatigue...
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sent...sonanceImaging(MRI)coilsandsoftwareandCalgaryScien...logies,haveintroducedawebversionofAegis(TM)Breast4...veinterfaceisthefirsttrulyzero-footprintWebclientb...tific,sPureWeb(TM)platformallowsforzero-footprinta...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNews...FDA,sCenterforDrugEvaluationandResearch,titled"ADi...,"appearsintheNov.26,2009issueofTheNewEnglandJourn...cgi-bin/prnh/20090824/FDALOGO ) ,, Inthearticle...naccesstopainmedicationforthosewhoneeditandmanagin...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...search Network is very near to achieving one of to...ge in the best possible health conditions.// ...nish universities of Seville, Oviedo, Saragossa, B...beings and present in many types of food – delays ...
...ev has launched a seven-day camp in this Taj Mahal...on sex and other licentious activities.// Ram...d, said he was opposed to sex education being give...vised the young to 'exercise restraint' rather tha...
... polluted river and a handful of concerned citizen...heralded World Earth Day Sunday, //by raising its ...ile ecosystem. 'We are on the brink of a cha... needs to be addressed immediately and a day such ...
...a massive immunization drive aimed at protecting m...eak. According to health experts, nearly 10% of th... Iraq's Ministry of Health is conducting the...ld Health Organization and UNICEF have got togethe...
... the US has sentenced a man to prison for conceali...to a plasma collection center at Hammond.// ...o selling blood contaminated with the HIV in Septe...a is the largest single component of blood, making...
...as combined nanotechnology and biology to enable t...rly results. Dr. Samuel is the director of the Ins...western University. He suggests that nanotechnolog...logy might achieve in regenerative medicine, paral...
Other Medicine News:Health News:High Melatonin can Help Delay Ageing 2Health News:Earth Day Celebrated With Hopes of a Greener Tomorrow 2Health News:Nanotechnology Could Treat Spinal Cord Injuries, Diabetes, and Parkinson's Disease 2
(Date:11/25/2009)...BRUNSWICK,N.J.,Nov.25/PRNewswire/--SwissrayInterna...ography( ddR )systems,announcedtodaythatitsoperati...gtermviewtowardsgrowingSwissray,smedicalimagingbra...roperty,aswellascontractsandinventory.After25years...xtleveloftechnologicaladvancementswithstableandste...
(Date:11/25/2009)...IEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(N...pingproductsforminimallydisruptivesurgicaltreatmen...ncecallonMonday,November30,2009,at5:30p.m.ET/2:30p...ativetoreimbursementfortheCompany,sproductsandwill...ionandanswersession.Thedial-innumbersare1-877-407-...
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, PainManagement-GlobalTrends ,, h...t---Global-Trends.html ,, Widespreadavailabili...andtheadventofnewdrugshaveacceleratedthepaceofgrow...imbursementstructurecontinuetoshapedemandforservic...
Breaking Medicine Technology:Swissray International Announces New Ownership 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 1Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 3CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 1CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 2CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 3
... - Cytogen,Corporation (NASDAQ: CYTO) today announ...shed at upcoming major medical meetings. The,data ...QUADRAMET(R),(samarium Sm-153 lexidronam injection...astatic bone disease arising from prostate,cancer ...,evaluating the outcomes of prostate cancer patien...
...-- Once-daily,dosing with Otsuka,s investigational... antagonist, was associated with improvements,in s...ailure (ADHF),in hospitalized patients receiving c...ir long-term survival versus placebo.(1) These,dat...e,international landmark trial Efficacy of Vasopre...
Other Medicine Technology:New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 2New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 4New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
... Touch control panel with 3 charging wells. Availa...Blue and Cinnamon. Spring balanced refractor and s...ction for lifelong quality. Sealed hydraulic syste...ement. Chair back reclines manually to fully horiz...
...eveloped the patented HydroKeratome corneal cuttin...t and industry experts believe it will replace the...okeratome, currently used in the LASIK refractive ...Company has demonstrated that its proprietary tech...
2.5v Ophthalmoscope Set
3.5v Coaxial Ophthalmoscope Set
Medicine Products: